Global PD-1 and PD-L1 Immunotherapy Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 20-Jun-2023
No. of pages: 98

The PD-1 and PD-L1 Immunotherapy market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the PD-1 and PD-L1 Immunotherapy industry, and breaks down according to the type, application, and consumption area of PD-1 and PD-L1 Immunotherapy. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for PD-1 and PD-L1 Immunotherapy in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global PD-1 and PD-L1 Immunotherapy market covered in Chapter 11:

Merck

AstraZeneca

Roche

GlaxoSmithKline

Bristol-Myers Squibb

Innovent

Eli Lilly

F. Hoffmann-La Roche

Pfizer

Novartis

Jiangsu HengRui Medicine

In Chapter 3, on the basis of types, the PD-1 and PD-L1 Immunotherapy market from 2018 to 2028 is primarily split into:

PD-1 inhibitor

PD-L1 inhibitor

In Chapter 4, on the basis of applications, the PD-1 and PD-L1 Immunotherapy market from 2018 to 2028 covers:

Solid Tumors

Blood-related Tumors

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global PD-1 and PD-L1 Immunotherapy Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global PD-1 and PD-L1 Immunotherapy Market, By Product Type
3.1 Global PD-1 and PD-L1 Immunotherapy Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global PD-1 and PD-L1 Immunotherapy Sales and Market Share by Types (2018-2023)
3.1.2 Global PD-1 and PD-L1 Immunotherapy Revenue and Market Share by Types (2018-2023)
3.1.3 Global PD-1 and PD-L1 Immunotherapy Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global PD-1 and PD-L1 Immunotherapy Sales, Price and Growth Rate of PD-1 inhibitor (2018-2023)
3.4 Global PD-1 and PD-L1 Immunotherapy Sales, Price and Growth Rate of PD-L1 inhibitor (2018-2023)

4 Global PD-1 and PD-L1 Immunotherapy Market, By Applications
4.1 Global PD-1 and PD-L1 Immunotherapy Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global PD-1 and PD-L1 Immunotherapy Consumption and Market Share by Applications (2018-2023)
4.1.2 Global PD-1 and PD-L1 Immunotherapy Revenue and Market Share by Applications (2018-2023)
4.2 Solid Tumors
4.3 Blood-related Tumors

5 Global PD-1 and PD-L1 Immunotherapy Market, By Regions
5.1 Global PD-1 and PD-L1 Immunotherapy Market Sales and Market Share by Regions
5.1.1 Global PD-1 and PD-L1 Immunotherapy Sales by Regions (2018-2023)
5.1.2 Global PD-1 and PD-L1 Immunotherapy Sales Market Share by Regions (2018-2023)
5.2 Global PD-1 and PD-L1 Immunotherapy Market Revenue and Market Share by Regions
5.2.1 Global PD-1 and PD-L1 Immunotherapy Revenue by Regions (2018-2023)
5.2.2 Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America PD-1 and PD-L1 Immunotherapy Market Analysis
6.1 North America PD-1 and PD-L1 Immunotherapy Market Size
6.1.1 North America PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
6.1.2 North America PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
6.2 U.S. PD-1 and PD-L1 Immunotherapy Market Size
6.3 Canada PD-1 and PD-L1 Immunotherapy Market Size
6.4 Mexico PD-1 and PD-L1 Immunotherapy Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe PD-1 and PD-L1 Immunotherapy Market Analysis
7.1 Europe PD-1 and PD-L1 Immunotherapy Market Size
7.1.1 Europe PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
7.1.2 Europe PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
7.2 Germany PD-1 and PD-L1 Immunotherapy Market Size
7.3 United Kingdom PD-1 and PD-L1 Immunotherapy Market Size
7.4 France PD-1 and PD-L1 Immunotherapy Market Size
7.5 Italy PD-1 and PD-L1 Immunotherapy Market Size
7.6 Spain PD-1 and PD-L1 Immunotherapy Market Size
7.7 Russia PD-1 and PD-L1 Immunotherapy Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Analysis
8.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Size
8.1.1 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
8.2 China PD-1 and PD-L1 Immunotherapy Market Size
8.3 Japan PD-1 and PD-L1 Immunotherapy Market Size
8.4 South Korea PD-1 and PD-L1 Immunotherapy Market Size
8.5 Australia PD-1 and PD-L1 Immunotherapy Market Size
8.6 India PD-1 and PD-L1 Immunotherapy Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Analysis
9.1 Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Size
9.1.1 Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia PD-1 and PD-L1 Immunotherapy Market Size
9.3 UAE PD-1 and PD-L1 Immunotherapy Market Size
9.4 Egypt PD-1 and PD-L1 Immunotherapy Market Size
9.5 South Africa PD-1 and PD-L1 Immunotherapy Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America PD-1 and PD-L1 Immunotherapy Market Analysis
10.1 South America PD-1 and PD-L1 Immunotherapy Market Size
10.1.1 South America PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
10.1.2 South America PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
10.2 Brazil PD-1 and PD-L1 Immunotherapy Market Size
10.3 Argentina PD-1 and PD-L1 Immunotherapy Market Size
10.4 Columbia PD-1 and PD-L1 Immunotherapy Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Merck
11.1.1 Merck Basic Information
11.1.2 Merck Product Profiles, Application and Specification
11.1.3 Merck PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.2 AstraZeneca
11.2.1 AstraZeneca Basic Information
11.2.2 AstraZeneca Product Profiles, Application and Specification
11.2.3 AstraZeneca PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.3 Roche
11.3.1 Roche Basic Information
11.3.2 Roche Product Profiles, Application and Specification
11.3.3 Roche PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Basic Information
11.4.2 GlaxoSmithKline Product Profiles, Application and Specification
11.4.3 GlaxoSmithKline PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Basic Information
11.5.2 Bristol-Myers Squibb Product Profiles, Application and Specification
11.5.3 Bristol-Myers Squibb PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.6 Innovent
11.6.1 Innovent Basic Information
11.6.2 Innovent Product Profiles, Application and Specification
11.6.3 Innovent PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.7 Eli Lilly
11.7.1 Eli Lilly Basic Information
11.7.2 Eli Lilly Product Profiles, Application and Specification
11.7.3 Eli Lilly PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.8 F. Hoffmann-La Roche
11.8.1 F. Hoffmann-La Roche Basic Information
11.8.2 F. Hoffmann-La Roche Product Profiles, Application and Specification
11.8.3 F. Hoffmann-La Roche PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.9 Pfizer
11.9.1 Pfizer Basic Information
11.9.2 Pfizer Product Profiles, Application and Specification
11.9.3 Pfizer PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.10 Novartis
11.10.1 Novartis Basic Information
11.10.2 Novartis Product Profiles, Application and Specification
11.10.3 Novartis PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)
11.11 Jiangsu HengRui Medicine
11.11.1 Jiangsu HengRui Medicine Basic Information
11.11.2 Jiangsu HengRui Medicine Product Profiles, Application and Specification
11.11.3 Jiangsu HengRui Medicine PD-1 and PD-L1 Immunotherapy Market Performance (2018-2023)

12 Global PD-1 and PD-L1 Immunotherapy Market Forecast, By Type and Applications
12.1 Global PD-1 and PD-L1 Immunotherapy Market Forecast by Types (2023-2028)
12.1.1 Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global PD-1 and PD-L1 Immunotherapy Market Forecast by Applications (2023-2028)
12.2.1 Global PD-1 and PD-L1 Immunotherapy Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global PD-1 and PD-L1 Immunotherapy Market Forecast, By Regions
13.1 Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America PD-1 and PD-L1 Immunotherapy Market Forecast (2023-2028)
13.4 Europe PD-1 and PD-L1 Immunotherapy Market Forecast (2023-2028)
13.5 Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Forecast (2023-2028)
13.6 Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Forecast (2023-2028)
13.7 South America PD-1 and PD-L1 Immunotherapy Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table PD-1 and PD-L1 Immunotherapy Key Market Segments
Figure Global PD-1 and PD-L1 Immunotherapy Market Size and Growth Rate 2018-2028
Figure Channel Status of PD-1 and PD-L1 Immunotherapy
Table Market Driving Factors of PD-1 and PD-L1 Immunotherapy
Table Market Industry Constraints and Challenges of PD-1 and PD-L1 Immunotherapy
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global PD-1 and PD-L1 Immunotherapy Sales by Types (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Sales Share by Types (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue ($) by Types (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue Share by Types (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Price by Types (2018-2023)
Figure Global PD-1 inhibitor Sales and Growth Rate (2018-2023)
Figure Global PD-1 inhibitor Price (2018-2023)
Figure Global PD-L1 inhibitor Sales and Growth Rate (2018-2023)
Figure Global PD-L1 inhibitor Price (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Consumption by Applications (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Consumption Share by Applications (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue ($) by Applications (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue Share by Applications (2018-2023)
Figure Global Solid Tumors Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Blood-related Tumors Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global PD-1 and PD-L1 Immunotherapy Sales and Growth Rate (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Sales by Regions (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Sales Market Share by Regions (2018-2023)
Figure Global PD-1 and PD-L1 Immunotherapy Sales Market Share by Regions in 2022
Figure Global PD-1 and PD-L1 Immunotherapy Revenue and Growth Rate (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue by Regions (2018-2023)
Table Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Regions (2018-2023)
Figure Global PD-1 and PD-L1 Immunotherapy Revenue Market Share by Regions in 2022
Figure North America PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Table North America PD-1 and PD-L1 Immunotherapy Sales by Countries (2018-2023)
Figure North America PD-1 and PD-L1 Immunotherapy Market Revenue ($) and Growth Rate (2018-2023)
Table North America PD-1 and PD-L1 Immunotherapy Revenue ($) by Countries (2018-2023)
Figure U.S. PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure U.S. PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Canada PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Canada PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Mexico PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Mexico PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Table Europe PD-1 and PD-L1 Immunotherapy Sales by Countries (2018-2023)
Figure Europe PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Table Europe PD-1 and PD-L1 Immunotherapy Revenue by Countries (2018-2023)
Figure Germany PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Germany PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure United Kingdom PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure France PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure France PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Italy PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Italy PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Spain PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Spain PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Russia PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Russia PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific PD-1 and PD-L1 Immunotherapy Sales by Countries (2018-2023)
Figure Asia-Pacific PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific PD-1 and PD-L1 Immunotherapy Revenue by Countries (2018-2023)
Figure China PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure China PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Japan PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Japan PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure South Korea PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure South Korea PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Australia PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Australia PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure India PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure India PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa PD-1 and PD-L1 Immunotherapy Sales by Countries (2018-2023)
Figure Middle East and Africa PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa PD-1 and PD-L1 Immunotherapy Revenue by Countries (2018-2023)
Figure Saudi Arabia PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure UAE PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure UAE PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Egypt PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Egypt PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure South Africa PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure South Africa PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure South America PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Table South America PD-1 and PD-L1 Immunotherapy Sales by Countries (2018-2023)
Figure South America PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Table South America PD-1 and PD-L1 Immunotherapy Revenue by Countries (2018-2023)
Figure Brazil PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Brazil PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Argentina PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Argentina PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Figure Columbia PD-1 and PD-L1 Immunotherapy Market Sales and Growth Rate (2018-2023)
Figure Columbia PD-1 and PD-L1 Immunotherapy Market Revenue and Growth Rate (2018-2023)
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2018-2023
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2018-2023
Table AstraZeneca Company Profile
Table AstraZeneca Production, Value, Price, Gross Margin 2018-2023
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2018-2023
Table Roche Company Profile
Table Roche Production, Value, Price, Gross Margin 2018-2023
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2018-2023
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2018-2023
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Value ($) Market Share 2018-2023
Table Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2018-2023
Figure Bristol-Myers Squibb Production and Growth Rate
Figure Bristol-Myers Squibb Value ($) Market Share 2018-2023
Table Innovent Company Profile
Table Innovent Production, Value, Price, Gross Margin 2018-2023
Figure Innovent Production and Growth Rate
Figure Innovent Value ($) Market Share 2018-2023
Table Eli Lilly Company Profile
Table Eli Lilly Production, Value, Price, Gross Margin 2018-2023
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Value ($) Market Share 2018-2023
Table F. Hoffmann-La Roche Company Profile
Table F. Hoffmann-La Roche Production, Value, Price, Gross Margin 2018-2023
Figure F. Hoffmann-La Roche Production and Growth Rate
Figure F. Hoffmann-La Roche Value ($) Market Share 2018-2023
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2018-2023
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2018-2023
Table Novartis Company Profile
Table Novartis Production, Value, Price, Gross Margin 2018-2023
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2018-2023
Table Jiangsu HengRui Medicine Company Profile
Table Jiangsu HengRui Medicine Production, Value, Price, Gross Margin 2018-2023
Figure Jiangsu HengRui Medicine Production and Growth Rate
Figure Jiangsu HengRui Medicine Value ($) Market Share 2018-2023
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales by Types (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales Share by Types (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue ($) by Types (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue Share by Types (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Consumption by Applications (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Consumption Share by Applications (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue ($) by Applications (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue Share by Applications (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales by Regions (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Sales Share by Regions (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue ($) by Regions (2023-2028)
Table Global PD-1 and PD-L1 Immunotherapy Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Surgical Overalls Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Surgical Overalls market was valued at US$ 679.9 million in 2023 and is anticipated to reach US$ 870.5 million by 2030, witnessing a CAGR of 3.1% during The forecast period 2024-2030. According to our research, The global market for medical devices is estimated at US$ 603 billion in The year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of The global GDP and is continuously rising in recent years ......
  • Global Medical or Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Medical or Healthcare market size was valued at US$ million in 2023. With growing demand in downstream market, the Medical or Healthcare is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Medical or Healthcare market. Medical or Healthcare are expected to show stable growth in the future market. However, product differ......
  • Global Hospital Gas Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Hospital Gas market size was valued at US$ million in 2023. With growing demand in downstream market, the Hospital Gas is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hospital Gas market. Hospital Gas are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Nurse Call Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global Nurse Call Systems market size was valued at US$ 1633.1 million in 2023. With growing demand in downstream market, the Nurse Call Systems is forecast to a readjusted size of US$ 3280.4 million by 2030 with a CAGR of 10.5% during review period. The research report highlights the growth potential of the global Nurse Call Systems market. Nurse Call Systems are expected to show stable growth in the future market. However, product......
  • Global Pediatric Healthcare Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 118
    According to our LPI (LP Information) latest study, the global Pediatric Healthcare market size was valued at US$ 136230 million in 2023. With growing demand in downstream market, the Pediatric Healthcare is forecast to a readjusted size of US$ 177330 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Pediatric Healthcare market. Pediatric Healthcare are expected to show stable growth in the future market. However, ......
  • Global Telepharmacy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Telepharmacy market: According to our latest research, the global Telepharmacy market looks promising in the next 5 years. As of 2022, the global Telepharmacy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Telepharmacy market, with a systema......
  • Global Vinca Alkaloid Compounds Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Vinca Alkaloid Compounds market: According to our latest research, the global Vinca Alkaloid Compounds market looks promising in the next 5 years. As of 2022, the global Vinca Alkaloid Compounds market was estimated at USD 26.93 million, and it's anticipated to reach USD 44.76 million in 2028, with a CAGR of 8.84% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of th......
  • Global Bladder Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 116
    Market Overview of Global Bladder Cancer market: According to our latest research, the global Bladder Cancer market looks promising in the next 5 years. As of 2022, the global Bladder Cancer market was estimated at USD 3886.47 million, and it's anticipated to reach USD 13709.57 million in 2028, with a CAGR of 23.38% during the forecast years. Bladder cancer is a disease in which cells in the urinary bladder start growing abnormally and uncontrollably. The main types of bladde......
  • Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 115
    Market Overview of Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market: According to our latest research, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market looks promising in the next 5 years. As of 2022, the global Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs